Percutaneous Pulmonary Valve Implantation; Current Status and Future Perspectives

(E-pub Ahead of Print)

Author(s): Bart W. Driesen*, Evangeline G. Warmerdam, Gert-Jan T. Sieswerda, Folkert J. Meijboom, Mirella C. Molenschot , Gregor J. Krings, Arie P.J. van Dijk, Michiel Voskuil.

Journal Name: Current Cardiology Reviews

Submit Manuscript
Submit Proposal


Patients with congenital heart disease (CHD) with right ventricle outflow tract (RVOT) dysfunction need sequential pulmonary valve replacements throughout their life in the majority of cases. Since their introduction in 2000, the number of percutaneous pulmonary valve implantations (PPVI) has grown and reached over 10,000 procedures worldwide. Overall, PPVI has been proven safe and effective, but some anatomical variations can limit procedural success. This review discusses the current status and future perspectives of the procedure.

Keywords: congenital heart disease, right ventricular outflow tract dysfunction, percutaneous pulmonary valve implantation, transcatheter pulmonary valve replacement, Melody, Sapien.

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1573403X15666181224113855
Price: $95

Article Metrics

PDF: 3